论文部分内容阅读
亚临床甲状腺功能减退症(SCH,以下简称亚临床甲减)是介于正常甲状腺功能与临床甲状腺功能减退症之间的中间状态。随着现代科学技术的发展和人们健康意识的提高,亚临床甲减检出率明显升高。越来越多的研究显示,亚临床甲减像肥胖、吸烟、糖尿病一样可导致心血管疾病的发病风险升高。故本文就甲状腺激素与心血管系统的联系,亚临床甲减与心血管疾病风险间的关联,及亚临床甲减患者是否应进行干预治疗等研究进展做一综述。
Subclinical hypothyroidism (SCH, hereinafter referred to as subclinical hypothyroidism) is intermediate between normal thyroid function and clinical hypothyroidism. With the development of modern science and technology and the improvement of people’s health awareness, the detection rate of subclinical hypothyroidism increased significantly. More and more studies have shown that subclinical hypothyroidism, like smoking, diabetes and diabetes mellitus, can lead to an increased risk of cardiovascular disease. Therefore, this article reviews the research progress of the relationship between thyroid hormone and cardiovascular system, the association between subclinical hypothyroidism and cardiovascular disease risk, and whether subclinical hypothyroidism should be intervened or not.